A research approach combining microbial proxies and soil organic matter fractionation with next-generation models to quantify and evaluate agricultural soil carbon sequestration efficacy, enabling data-driven assessment of farming practices for carbon storage.
This research addresses the challenge of accurately measuring and modeling agricultural carbon sequestration by focusing on the microbial mechanisms that drive soil organic carbon (SOC) persistence. The approach couples microbial activity metrics with soil organic matter (SOM) fractionation and advanced modeling to quantify how agricultural practices contribute to long-term soil carbon storage. By evaluating practices through microbial and biogeochemical lenses, the work enables more reliable assessment of carbon sequestration efficacy in agricultural systems.
Core measurement framework:
Key insight: Mineral-associated organic matter, derived primarily from microbial necromass, correlates more strongly with persistent SOC than particulate organic matter, making microbial proxies effective indicators of long-term carbon storage potential.
This research is at an early-to-mid stage of development. Future validation will be conducted using soil samples from the Oxford College Organic Farm at Emory University, where organic farming practices have been maintained since 2014, providing a well-characterized long-term experimental site. The approach integrates established microbial tracing methods (13C labeling, H218O uptake) with proven SOM fractionation techniques and computational modeling. Further validation through field-scale application and cross-site comparison would advance the framework toward broader deployment.
Emory University is a comprehensive private research university in Atlanta, anchored by a major academic health center and a mid-sized, research-active faculty. Integration with its academic health system provides direct access to patients, clinicians, and real-world data, enabling rapid clinical translation and large, multisite trials. A hospital-embedded innovation hub and proximity to the CDC and Atlanta’s corporate ecosystem create frequent pathways for co-development, testing, and deployment with industry partners; a long-standing partnership with a neighboring engineering powerhouse broadens prototyping and scale-up options. Research is supported by competitive federal funding, including the National Institutes of Health and the National Science Foundation. A dedicated technology transfer office supports IP strategy, licensing, startup formation, and streamlined industry agreements.